Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Volpe

Showing results (101-110 of 820) with videos related to

Pageof 82
Sort By:
European Heart Journal|February 9, 2022
Drugs may worsen blood pressure control: focus on the underestimated role of non-steroidal anti-inflammatory drugsMassimo Volpe, Carlo Patrono
Journal of Hypertension|May 31, 2019
An evolutionary rebus: the complex link between malaria and hypertensionMassimo Volpe, Allegra Battistoni
European Heart Journal|March 24, 2022
Unloading left heart with a shunt device shows no benefits in heart failure with preserved ejection fraction but supports the importance of phenotyping patients in clinical trialsMassimo Volpe, Giovanna Liuzzo
European Heart Journal|June 1, 2024
Weekly Journal Scan: a novel RNA-based approach to the treatment of hypertriglyceridaemiaLeonarda Galiuto, Massimo Volpe
European Heart Journal|February 12, 2026
Weekly Journal Scan: VESALIUS-CV extends PCSK9 inhibition to the prevention of first major cardiovascular eventsGiovanna Liuzzo, Massimo Volpe
Expert Review of Cardiovascular Therapy|June 10, 2010
Challenging hypertension: how to diagnose and treat resistant hypertension in daily clinical practiceMassimo Volpe, Giuliano Tocci
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Synergistic effects of cardiac resynchronization therapy and drug up-titration in heart failure: is this enough?Massimo Volpe, Pietro Francia
European Heart Journal|September 28, 2023
Light the FIRE of revascularization in older patients with myocardial infarctionRocco Vergallo, Massimo Volpe
European Heart Journal|February 15, 2021
PCSK9 inhibition: Not just LDL-Cholesterol knock down: A glimmer for cancerCarlo Patrono, Massimo Volpe
Journal of Hypertension|August 1, 2019
How much drug-induced blood pressure reduction is effective and safe in heart failure?Sebastiano Sciarretta, Massimo Volpe
Pageof 82

Showing results (101-110 of 820) with videos related to

Sort By:
Pageof 82
European Heart Journal|February 9, 2022
Drugs may worsen blood pressure control: focus on the underestimated role of non-steroidal anti-inflammatory drugsMassimo Volpe, Carlo Patrono
Journal of Hypertension|May 31, 2019
An evolutionary rebus: the complex link between malaria and hypertensionMassimo Volpe, Allegra Battistoni
European Heart Journal|March 24, 2022
Unloading left heart with a shunt device shows no benefits in heart failure with preserved ejection fraction but supports the importance of phenotyping patients in clinical trialsMassimo Volpe, Giovanna Liuzzo
European Heart Journal|June 1, 2024
Weekly Journal Scan: a novel RNA-based approach to the treatment of hypertriglyceridaemiaLeonarda Galiuto, Massimo Volpe
European Heart Journal|February 12, 2026
Weekly Journal Scan: VESALIUS-CV extends PCSK9 inhibition to the prevention of first major cardiovascular eventsGiovanna Liuzzo, Massimo Volpe
Expert Review of Cardiovascular Therapy|June 10, 2010
Challenging hypertension: how to diagnose and treat resistant hypertension in daily clinical practiceMassimo Volpe, Giuliano Tocci
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Synergistic effects of cardiac resynchronization therapy and drug up-titration in heart failure: is this enough?Massimo Volpe, Pietro Francia
European Heart Journal|September 28, 2023
Light the FIRE of revascularization in older patients with myocardial infarctionRocco Vergallo, Massimo Volpe
European Heart Journal|February 15, 2021
PCSK9 inhibition: Not just LDL-Cholesterol knock down: A glimmer for cancerCarlo Patrono, Massimo Volpe
Journal of Hypertension|August 1, 2019
How much drug-induced blood pressure reduction is effective and safe in heart failure?Sebastiano Sciarretta, Massimo Volpe
Pageof 82